瑞典LAPPRO试验中开放与机器人根治性前列腺切除术24个月随访的功能与肿瘤学结局
LAPPRO是一项前瞻性多中心试验,从瑞典14个中心纳入4003例临床局限性前列腺癌患者,比较机器人辅助腹腔镜根治性前列腺切除术(RALP)与开放耻骨后根治性前列腺切除术(RRP)。24个月随访显示,RALP在勃起功能障碍方面优于RRP(68% vs 74%;AOR 0.72,95%CI 0.57-0.91;p=0.006),尿失禁和复发或残留病灶无显著差异。
要点
- 24个月随访时RALP组勃起功能障碍68% vs RRP组74%,AOR 0.72(95%CI 0.57-0.91;p=0.006)。
- 尿失禁RALP组19% vs RRP组16%,AOR 1.29(95%CI 1.00-1.67;p=0.053),无显著差异。
- 复发或残留病灶两组均为13%,AOR 0.79(95%CI 0.59-1.07;p=0.13),无显著差异。
核心结论
- 延长随访至24个月证实了此前12个月报告的RALP在勃起功能方面的持续获益。
研究设计与样本
- 前瞻性多中心LAPPRO试验,从瑞典14个中心(7个开展RALP,7个开展RRP)纳入4003例临床局限性前列腺癌患者。
- 仅分析由既往完成超过100例根治性前列腺切除术的外科医生手术的患者,并使用逻辑回归计算调整比值比(AOR),校正患者构成差异。
主要发现
- 24个月时勃起功能障碍RALP组68% vs RRP组74%,AOR 0.72(95%CI 0.57-0.91;p=0.006),差异显著有利于RALP。
- 尿失禁RALP组19% vs RRP组16%,AOR 1.29(95%CI 1.00-1.67;p=0.053),无显著差异。
- 复发或残留病灶RALP组13% vs RRP组13%,AOR 0.79(95%CI 0.59-1.07;p=0.13),无显著差异。
局限性
- 未校正个体外科医生的手术量和经验,这是一个潜在局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The adoption of robot-assisted laparoscopic radical prostatectomy (RALP) has increased rapidly, despite lack of conclusive evidence of its superiority regarding long-term outcomes over open retropubic RP (RRP). In 2015, we reported on 12-mo follow-up from the LAPPRO trial showing a moderate advantage of RALP regarding erectile dysfunction. No significant differences were seen for urinary incontinence or surgical margin status. OBJECTIVE: To present patient-reported functional outcomes and recurrent and residual disease at 24-mo follow-up from the prospective multicenter LAPPRO trial. DESIGN, SETTING, AND PARTICIPANTS: A total of 4003 patients with clinically localized prostate cancer were recruited from 14 Swedish centers, seven performing RALP and seven RRP. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Data were only analyzed for patients operated on by surgeons with >100 prior RPs. Adjusted odds ratios (AORs) were calculated using logistic regression, with adjustment for differences in patient mix. RESULTS AND LIMITATIONS: At 24 mo, there was a significant difference in erectile dysfunction in favor of RALP (68% vs 74%; AOR 0.72, 95% confidence interval [CI] 0.57-0.91; p=0.006). No significant difference was observed for incontinence (19% vs 16%; AOR 1.29, 95% CI 1.00-1.67; p=0.053) or recurrent or residual disease (13% vs 13%; AOR 0.79, 95% CI 0.59-1.07; p=0.13). We did not adjust for individual surgeon volume and experience, which is a potential limitation. CONCLUSIONS: Extended follow-up corroborated our previous report at 12 mo of a persistent RALP benefit regarding potency. PATIENT SUMMARY: LAPPRO is a Swedish trial comparing two different prostate cancer surgical techniques (robotic compared to open). At 24-mo follow-up after surgery there was a moderate advantage for the robotic technique regarding erectile dysfunction (potency), while there was a small but not significant difference in urinary leakage in favor of open surgery. We did not find any difference regarding cancer relapse.
引用
- Nyberg M, Hugosson J, Wiklund P, et al. Functional and Oncologic Outcomes Between Open and Robotic Radical Prostatectomy at 24-month Follow-up in the Swedish LAPPRO Trial. Eur Urol Oncol. 2018. PMID: 31158073. doi:10.1016/j.euo.2018.04.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。